plz learn this Flashcards

1
Q

zofran dose

adults
kids

A

adults: 4-8 mg Iv over 2 minutes ->HA
kids: 0.05 to 0.15 mg/kg IV - careful

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

reglan dose

A

10-20 mg over 3-5 min -> abd cramping

peds T&A: 0.15 mg/kg slowly/ after

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

CV effects of reglan

A

increase HR
decrease BP

c/I with pheochromocytoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

omeprazole is given as a

A

pro-drug is protonated to active form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MOA of omeprazole

A

irreversibly inhibits H/K pump in gastric parietal cells, decreasing secretion of gastric acid and H+.
decreases gastric acid volume, increases gastric acid ph

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

bicitra is C/I in

A

pts taking aluminum salt ant acids
severe renal impairment
low sodium diet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

antacids can result in increased rate of absorption of

A

salicylates
indomethacin.
naproxen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

antacids with acid rebound

A

Na bicarb

calcium carbonate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

H1 receptors are located at

A

bronchial smooth muscle (bronchoconstriction)
GI smooth muscle (Constriction)
vascular smooth muscle - (VASODILATION)
vascular endothelial cells (edema/permeability)
peripheral nerve endings - itching
Heart! AV node - SLOWS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

H2 receptors are located at

A

proton pumps of gastric parietal cells - increase acid
heart -positive inotoropic and chronotropic effect
airway - bronchodilator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

CV Side Effects of Benadryl

A

tachycardia

hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Benadryl is C/I in

A

acute asthma?
CV disease r/t hypotension and tachycardia
increase IOP! (ach antagonism - mydriasis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MOA H2 receptor antagonists:

A

block H2 receptor effects in gastric parietal cells, decrease cAMP, decrease H+ secretion, decrease gastric acid secretion.

does not change volume or pH of what is already in stomach.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

least potent H2 antagonist

A

cimetidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

dose of cimetidine

A

300 mg IV over 15-30 minutes 1-2 hrs pre-op

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

cimetidine C/I in

A

asthma
caution in renal failure (excreted 75%)
caution in liver failure (transient increase in LFTs)

**INHIBITS CYP450
prolonged effect of WARFARIN, DIAZPEAM, LIDOCAINE, PROPANOLOL, MOPRHINE, CCB, TCAs, phenytoin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

most potent H2 receptor antagonist

A

famotidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

dose of ranitidine

A

50 mg IV over 15-30 minutes, 1-2 hrs pre-op
give slowly.

50% excreted unchanged.
pulled r/t Ca risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

dose of famotidine

A

50 mg IV over 2 minutes, can give faster.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

SE of H2 receptor antagonists

A

delayed awakening from anesthesia
decrease HBF, transient increase in LFTs,
HA, fatigue, dizziness, confusion
arrthymias
rapid administration - hypotension, bradycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q
Dicyclomine - class 
uses:
A

dicyclomine is an anti-cholinergic,
used to decrease gastric acid secretion.

It has a poor therapeutic window, many interactions and is LESS effective than H2 antagonists and PPis

SE: Dry mouth, constipation, blurred vision, cardiac arrthymias , urinary retention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

famotidine PK
onset:
DOA

A

famotidine
onset- 30 minutes (others are 1 hour)
DOA: 8 hours (others are 4 hours)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Sucralafate!

A

is a barrier drug

coats the gastric lining of the stomach to prevent further ulceration

does NOT change pH

SE
constipation, flatulence, little systemic absorption, drug interactions via binding to drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Colloidal Bismuth?

A

also a barrier drug.

stimulation of mucosal bicarbonate and PGE2, inhibits h. pylori growth, protects stomach from further ulceration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Misoprostol

A

is a prostaglandin analogue.

give to pts on NSAIDs to prevent NSAID induced ulcers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Aprepitant (Emend?)

A

Substance P antagonist.

little to not affinity for serotonin, d dopamine, corticosteroid receptors.

very effective!
used in oncology and often with agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Scopalamine dose

A

5 mcg/hr for 72 hr patch.

usually must be put-on 4 hours in advance for best results

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

scopolamine is C/I in

A

glaucoma, MG, tachycardia r/t CV issues
GI/GU obstruction
paralytic ileus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

scopolamine decreases

A

effects of acetaminophen and levodopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

stats on statins

HDL/LDL/TG

A

statins:
decrease LDL: 20-60%
increase HDL: 10%
decrease TG: 10-20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Niacin + statin =

A

increased r/f myopathy

increased r/f hepatotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Gemfibrozil + statin =

A

increased r/f myopathy
increased r/f hepatoxicity
also! DECREASED TG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

increased r/f myopathy with statins:

A
preexisting muscle condition 
>80 y/o
female 
asian 
smaller body frame 
hypothyroid 
impaired renal function
impaired hepatic function 
ETOH abuse 
High statin level
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

pravastatin differences

A

not highly PB and not highly metabolized by cYP450

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

CYP3A4 inhibits will increase concentration of…

A

prodrug statins!!
simvastatin
lovastatin

CYP3A4 inhibits:
grapefruit, verapamil, amiodarone, erythropoietin, clarithro, azole antifungals, coumadin, cyclosporine, protease inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Dabigatran +simva/lova =

A

high risk for bleeding.

now have reversal agent for dabigatrarin (prdxbind?)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

cyclosporine increases

A

concentration of all statins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

bile acid-binding, resin sequestrin stats

A

Decrease LDL
increase HDL
no effect on TG

  • get rid of more bile via GI
  • getting rid of cholesterol will also increased LDL receptors

cholestyramine, colestipol, colesevlam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

bild acid resins can interfere with

A

PO absorption of drugs

synthroid
OC
suflas 
phenytoin 
thiazides
fat soluble vitamins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

in small/young pts, cholecystramine can cause

A

hyperchloremic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

resins + statins

A

further decrease in LDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

only pregnancy safe anti-cholesterol =

A

binding resins (cholecystryamine, colestipol, colesevalem)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Niacin MOA

A

acts on liver and adipose tissue to decrease TG, unsure why increase in HDL, does decrease LDL - not very effective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Niacin stats

A

minor decrease in LDL (10-20%)
TG - decrease
HDL increase but unsure why

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

niacin is best for pts

A

at risk of pancreatitis
increases HDL more than any other drug
does little to improve long term outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Niacin SE

A

intense flushing - tx with ASA
GI upset
Hepatotoxicity - assess LFTs
Hyperglycemia - without DM, increases r/f DM
hyperuricemia - gout, increase fluid uptake, watch kidney function
visual changes

increased r/f myopathy and hepatotoxicity with statins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

most effective drug to decrease TG:

A

fiber acid derivative - gemfibrozil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Gemfibrozil MOA

A

increase synthesis of LPL
also decreases level of apolipoprotei that decrease LPL

LPL breaks down TG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Gemfibrozil stats

A
decrease TG (best)
also increase HDL!! (20%)
does very little to decrease LDL
50
Q

Gemfibrozil SE

A

Rahses/GI upset/ HA
rhabdo myopathy with statins
liver injury check LFTS - made worse with statins
GALLSTONES - dc
displaces warfarin - watch INR/ LFTs
potentiates oral anti-hyperglycemias - monitor
can increase serum level of statins

51
Q

Ezetimibe (Zetia) MOA

A

Inhibits cholesterol absorption from brush border of SI

52
Q

Ezetimibe is used to

A

decrease LDL

53
Q

Ezetimibe SE:

A
diarrhea
also gallstones -> D/C
may increase bleeding of warfarin 
iS INCREASED BY CYCLOSPORINE 
absorption of this drug would be inhibited by resins
54
Q

PCSK9 inhibitors MOA

A

block the enzyme that breaks down LDL receptors

increase LDL receptor expression

55
Q

PCSK9-i stats

A

PCSK9 inhibitor stats

DECREASE LDL significantly.

56
Q

PCSK9-I are a good choice for

A

pts who cant tolerate high dose statins, use statin + PCSK9

57
Q

mipomersen MOA

A

mipomersen MOA:
decrease apoB protein and decrease risk of CV disease

black box warning for fatty liver
also flu like symptoms

FDA approved for familial hyperlipidemia

58
Q

Lopitamide MOA

A

triglyceride transfer protein inhibitor in ER, prevents assembly of apoB, inhibits synthesis of chylomicrons.

50% reduction in plasma LDL levels **

59
Q

bronchodilation and cAMP

A

activation of b2 receptors will INCREASE cAMP and lead to bronchodilation

60
Q

inhaled corticosteroids

A

budesonide
beclomethasone
triamcinolone
fluticasone

61
Q

cromolyn MOA

A

Stablilizes mast cells

inhibits antigen induced release of mediators

62
Q

cromolyn must be taken

A

PROPHYLACTICALLY
must be taken 4 times daily
safest of all drugs tho

63
Q

Zileuton MOA:

A

Inhibits lipoxygenase, inhibits production of leukotrienes from arachidonic acid

64
Q

Zileuton SE:

A

hepatotoxic 2-4%

neuropsych: anxiety, depression, suicidal ideation, hallucinations

65
Q

zilueton is less effective than

A

inhaled corticosteroid and LABA

onset = 1-2 hours, not useful in acute attack

66
Q

montelukast mOA

A

cysLT1 receptor antagonist.

blocks the mechanism of bronchoconstriction and smooth muscle effects

67
Q

montelukast is used

A

to tx in asthma in pts <1 y/o
prevents exercise induced bronchospasm >15 y/o
treat allergic rhinitis

improves bronchial tone, pulmonary function, and asthma symptoms.

68
Q

montelukast max effect =

A

max effect = 24hrs after 1st dose

69
Q

omalizumab is used

A

in ALLERGY induced asthma when inhaled glucocorticoids have failed

70
Q

SE of omalizumab

A
injection site rxn 
increased r/f viral infxn 
URI / sinusitis 
HA 
Pharyngitis 
increased CV complications, 
possible increased r/f CA 

RARE adverse effect: triggering of an immune response (anaphylaxis)
monitor 2 hours after 1st 3 doses
monitor 30 minutes after all SQ doses

71
Q

SE of beta 2 agonists

A
SE; 
minimized by inhalation delivery 
tremor 
increased HR 
vasodilation 
metabolic changes: hyperglycemia, hypokalemia, hypomagnesemia
72
Q

terbutaline administer via SC resembles

A

epi response

73
Q

terbutaline dosage

A

terbutaline dosage for child:
0.1 mg/kg

terbutaline dosage for adult:
0.25 mg q 15 minutes

each dose is 200 mcg
max dose = 16-20 puffs/day

74
Q

Long acting B2 agonists differ in that

A

they have a lipophilic side chain that allows them to bind more tightly to B2

DOA: 12-24 hours

these are not for prevention, these work prophylactically

75
Q

long acting B2 agonists

A

salmeterol and formoterol

76
Q

black box warning for LABA

A

may increase the risk of fatal or near fatal asthma attack. now they are paired with steroids. No clear reason why this is better.

77
Q

methylxanthines MOA

A

Unclear.
Also called phosphodiesterase inhibitors

maybe prevent cAMP degradation in smooth muscle as well as in inflammatory cells

dRUG EFFECT: Airway relaxation and bronchodilation

78
Q

clinical indication for methylxanthines

A

COPD

ASTHMA

79
Q

SE of methylxanthines

A

multiple SE and a narrow therapeutic index

therapuetic index: 10-20 mcg/mL

toxic at >20mg/mL

wide 1/2 life variation in different patients, especially in smokers who metabolize 50% faster

SE: 
Cardiac arrhthymias 
n/V 
Irritability 
insomnia 
seizures
brain damage
hyperglycemia 
hypokalemia 
hypotension 
dEATH FROM CV COLLAPSE
80
Q

Drug interactions with methylxanthines

A

metabolized by cYP450:

cimetidine, cipro, antifungals: cyp450 inhibitors - can INCREASE levels

phenobarbitals and phenytoin: can DECREASE levels

smoking can increase levels

caffeine can increase levels and promote CNS/CV toxicity

81
Q

Anticholinergics are used

A

to tx COPD

secondary line of tx for asthma in patients resistant to beta agonist or who have significant cardiac disease

82
Q

ipatropium bromide

A

is an anti-cholinergic agent
is a quartenary ammonium derivative of atropine - can’t cross BBB

SLOW onset 30-90 minutes
duration of action 4-6 hours
NOT significantly absorbed compared to atropine, so less SE, can have inadvertent oral absorption - GI upset, dry mouth

83
Q

Tiotropium

A

anti cholinergic
quaternary ammonium salt
not significantly absorbed
approved by FDA for COPD

84
Q

tiotropium/ipatropium is used in COPD as

A

maintenance and rescue therapy!

only used in asthma or ACUTE exacerbation

85
Q

SE of cromolyn

A

Safest of all anesthesia drugs.

infrequent SEs are 
cough / bronchospasm 
laryngeal edema 
angio edema 
urticaria 
anaphylaxis
86
Q

protamine sulfate dosing

A

1 mg protamine sulfate per 100 units heparin

give slowly, can cause drop in BP

87
Q

dabigatran is given as a

A

pro-drug

that is rapidly converted by plasma esterases into active form

88
Q

fondaparinux MOA

A

Is a LMW heparin, has a 5 sugar base, binds to anti-thrombin 3 and then binds to only Xa. No thrombin effect.

good in HIT,
can cause thrombocytopenia

more effective than other LMW heparin, so greater bleeding risk but less than heparin

89
Q

dabigatran MOA

A

DIRECT thrombin inhibitor.
pro drugs.
binds to free and bound thrombin.

90
Q

dabigatran pk

A
dabigatran 
onset; RAPID
e1/2life ; 13 hours 
pb: low 
primarily cleared by kidneys, encourage PO uptake
91
Q

drug interactions with dabigatran

A

Dabiagatran DDI:

  1. p-glycopreotein inhibitors will iNCREASE drug levels (amino, verapamil, ketoconazole, quinine),
  2. with simvastatin/lovastatin - major bleed, need reversal
92
Q

Surgical considerations for dabigatran

A

stop 48 hours before surgery with normal renal function.

stop 72-96 hours before surgery with impaired renal function.

stop 5 days before surgery if high risk for bleed during surgery

93
Q

reversal agent for rivaroxaban

A

andexxa

94
Q

surgical considerations for rivaroxaban

A

hold 48 hours pre-op

hold 5 days if high risk for bleeds

95
Q

dypridamole is used often

A

following heart valve replacement

96
Q

dypridamole + ASA =

A

stroke prevention

“aggrenox”

97
Q

dypridamole requires

A

BID dosing

98
Q

Dypridamole SE

A
HA, hypotension - vasodilation 
bronchospasm, dyspnea 
MI
arrthymias
nausea, dizziness 
rash/flushing
99
Q

abciximab used for

A

unstable angina, acute MI

PCI

100
Q

tpa + ACE-i

A

increased risk for angio edema

101
Q

anti-plt drugs are not recommended for patients with

A

severe hepatic disease or patients with GI ulcers

102
Q

ADP receptor antagonists act for

A

the LIFE of the plt. 7-10 days

exception: Ticagrelor

103
Q

bare metal stents and drug eluding stents require

A

6 weeks and 6 months for seeding, post pone elective surgery until after this period

104
Q

if no stent and pt on plavix and HIGH risk

A

dc 5 days before. placid washout,
resume 24 hrs post - op
use ASA in between

105
Q

no stent, on plavix, LOW risk

A

dc 7-10 days prior

resume 24 hrs post -op

106
Q

TXA dose

A

1 gm in 100 mL Ns given over 10 minutes [loading]

followed by 1 gm in 100 ml NS over 8 hours

107
Q

pk of TXA

A

95% excreted, decease dose in renal failure

108
Q

SE of TXA

A

seizures
vision changes
ureteral obstruction and bleeding
renal toxicity

109
Q

opioid that is always combined with something else

A

HYDROcodone

ASA, ibuprofen, anti-histamine, acetaminophen

110
Q

diphenyl derivative =

A

methadone

111
Q

MOA of acetaminophen

A

unclear
NMDA receptor antagonist in CNS
substance P ANTAGONIST in spinal cord

112
Q

NSAIDs displace

A

highly PB drugs

warfarin
phenytoin
sulfonylureas
sulfonamides
digoxin
113
Q

NSAIDs decrease effectiveness of

A

diuretics
beta blockers
ace I

INCREASElithium levels

114
Q

Celecoxbin dosing

A

<200 mg/day

115
Q

ketorolac dosing

A

30 mg IV or Im x 1 q 6 hours
max - 120 mg

cut doses by 50% in elderly

do not exceed 5 days of use

116
Q

hydrochlorothiazide clearance

A

100% in urine

117
Q

dose of hydrochlorothiazide

A

25 mg - 100 mg / day
max: 200 mg day
low ceiling effect

118
Q

hydrochlorothiazide is synergistic with

A

ACE-I or BB

NSAIDs DECREASE efficacy

119
Q

Hydrochlorothiazide is C/I in

A

renal failure , Anura
decrease dose in elderly,
anti-arrthymic agents that prolong QTI

120
Q

dose of mannitol

A

0.25 to 1 g/kg IV

over 30-60 minutes